Entrada de Pandipedia

Actualizado el 10 Oct 20265 fuentesExplorar Pandipedia

ESG Librarypor Pandi3 mes

Early ESRS: 3 bottlenecks before comparability

Early ESRS may bring high-level comparability first; datapoint-level comparisons may remain uneven. The challenge is execution: evidence-based double materiality, deciding which datapoints matter, and mapping where value-chain impacts, risks and opportunities sit. EFRAG says its datapoint list is a practical aid, not a full materiality answer. Usable data and expert input are needed early, and broad value-chain labels need a materiality-driven map. Phase-in relief applies where allowed.

Sigue explorando

From materiality to machine readability: the ESRS reporting workflow. Structure the report as an end-to-end ESRS implementation map: evidence-based materiality assessment, datapoint scoping, metric definitions, reporting boundaries, internal controls, assurance readiness, and XBRL tagging. Use tables to show what each function owns and where comparability, verification, and value chain data risks enter the process.Should KEV outrank CVSS in vulnerability triage?. Compare severity-only triage with exploitation-led triage using KEV, EPSS, vendor remediation status, and asset exposure as the core decision inputs. Include a table separating confirmed exploitation, probability of exploitation, remediation action, and when to remove unpatchable assets from networks.Which UK procurement signals point to better competition?. Build a structured briefing for capture teams and analysts on what the first year of UK Procurement Act data says about open methods, direct awards, single-bid lots, pre-market engagement, SME participation, and remaining data gaps. Include practical watchpoints for opportunity qualification, incumbent analysis, and buyer monitoring.A Rock Pile That Looks Like Cheese De risking biotech supply chains lessons from semiconductor manufacturing. Compare just in time pitfalls, diversification tactics, and quality standards between chips and biologics. Offer actionable steps for biotech firms to buffer shocks.A deep dive into neurosymbolic AI and its promise for explainability. Traces the fusion of neural networks and symbolic reasoning, reviews current research, and outlines practical applications. Discusses hurdles and next steps.Behind market intelligence is a normalization engine QKD vs. Post-Quantum Cryptography: Which Should You Deploy?